Patent · US Active

Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4

US9771406B2 · kind B2 · utility

3Cited by

229References

31Claims

0Family size

Assignee

Sanofi · FR

Inventors

Martin Bossart · Frankfurt am Main, DE
Ralf Elvert · Frankfurt am Main, DE
Andreas Evers · Frankfurt am Main, DE
Torsten Haack · Frankfurt am Main, DE
Siegfried Stengelin · Frankfurt am Main, DE
Michael Wagner · Frankfurt am Main, DE
Katrin Lorenz · Frankfurt am Main, DE

Key dates

Filing date	Apr 6, 2015
Grant date	Sep 26, 2017
Priority date	—
Expiry date	Apr 6, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/605
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to dual GLP-1/glucagon receptor agonists or optionally trigonal GLP-1/glucagon/GIP receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.